Autopsy report · NCT00025298
Chemotherapy Plus Radiation Therapy With or Without Amifostine in Treating Patients With Locally Advanced Cancer of the Nasopharynx
Cause of deathSlow enrollment
“low accrual”
Life of this trial
- Registered 3 months after it had already started.
- 5 participants enrolled.
- No results are posted on the registry.
Vital statistics
- Status
- Terminated
- Phase
- Phase 2
- Sponsor
- European Organisation for Research and Treatment of Cancer - EORTC
- Sponsor type
- University, hospital or other
- Conditions
- Drug/Agent Toxicity by Tissue/Organ; Head and Neck Cancer; Oral Complications; Radiation Toxicity
- Interventions
- amifostine trihydrate; carboplatin; cisplatin; paclitaxel; radiation therapy
- Participants
- 5
- Sites
- 13
- Countries
- Belgium, France, Italy, Spain, Turkey (Türkiye), United Kingdom
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.